Abstract:Diagnosis facilitates the discovery of an impending disease. A complete and accurate treatment of cancer depends heavily on its early medical diagnosis. Cancer, one of the most fatal diseases world-wide, consistently affects a larger number of patients each year. Magnetism, a physical property arising from the motion of electrical charges, which causes attraction and repulsion between objects and does not involve radiation, has been under intense investigation for several years. Magnetic materials show great promise in the application of image contrast enhancement to accurately image and diagnose cancer. Chelating gadolinium (Gd III) and magnetic nanoparticles (MNPs) have the prospect to pave the way for diagnosis, operative management, and adjuvant therapy of different kinds of cancers. The potential of MNP-based magnetic resonance (MR) contrast agents (CAs) now makes it possible to image portions of a tumor in parts of the body that would be unclear with the conventional magnetic resonance imaging (MRI). Multiple functionalities like variety of targeting ligands and image contrast enhancement have recently been added to the MNPs. Keeping aside the additional complexities in synthetic steps, costs, more convoluted behavior, and effects in-vivo, multifunctional MNPs still face great regulatory hurdles before clinical availability for cancer patients. The trade-off between additional functionality and complexity is a subject of ongoing debate. The recent progress regarding the types, design, synthesis, morphology, characterization, modification, and the in-vivo and in-vitro uses of different MRI contrast agents, including MNPs, to diagnose cancer will be the focus of this review. As our knowledge of MNPs' characteristics and applications expands, their role in the future management of cancer patients will become very important. Current hurdles are also discussed, along with future prospects of MNPs as the savior of cancer victims.

A Portable Unilateral Nuclear Magnetic Resonance Magnet Designed for Breast Cancer Detection

Improved Configuration of Halbach Magnets with a Homogeneous Magnetic Field for Portable NMR Device

Breast Intervention Device for Low-Field MRI with a Customized Unilateral Coil

Development of a human-size magnetic particle imaging device for sentinel lymph node biopsy of breast cancer

Metamaterial-based Artificial magnetic conductor for efficient breast cancer diagnosis using a low-cost antenna array

Cu-MOF/Aptamer/Magnetic Bead Sensor for Detection of Breast Cancer Biomarkers HER2 and ER

A 72-year-old man with a mass in his right axilla.

Design and Control of a Novel Magnetic Resonance Imaging-Compatible Breast Intervention Robot

SQUID Magnetometry for Cancer Screening a Feasibility Study

Integrated Giant Magnetoresistance Technology for Approachable Weak Biomagnetic Signal Detections

Structural Defect‐Enabled Magnetic Neutrality Nanoprobes for Ultra‐High‐Field Magnetic Resonance Imaging of Isolated Tumor Cells In Vivo

Smart Bacterial Magnetic Nanoparticles for Tumor-Targeting Magnetic Resonance Imaging of HER2-Positive Breast Cancers.

Magnetic Nanoparticle-Based Cancer Nanodiagnostics

Single-sided magnetic resonance-based sensor for point-of-care evaluation of muscle

Portable Low-cost MRI System based on Permanent Magnets/Magnet Arrays

A Novel Hand-held Multi-color Magnetic Particle Imaging Device based on Rapid Frequency Conversion

Optical – Magnetic probe for evaluating cancer therapy

Electromagnet Design for Ultra-Low-field MRI

Estimating the location of the hook-wire used in breast-conserving surgery using a magnetometer

Ligand‐Mediated Magnetism‐Conversion Nanoprobes for Activatable Ultra‐High Field Magnetic Resonance Imaging

Biomarkers detection with magnetoresistance-based sensors